EW
Edwards Lifesciences Corp
- Latest sale
- $54k
- Sep 11 · Routine
- Form 4 sales
- 1,078
- On record
- Form 144 notices
- 24
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualJul 28 2026
Sold 9,628 shares at $85.06 ($819k)
Markowitz Wayne, CVP, JAPAC
No 10b5-1 planSold 30.8% of holdings ($2.7M position)21,680 shares left16.5x usual sizeFiling
- 2 Form 4 saleNo planJul 30 +2 days
Sold 146 shares at $86.03 ($13k)
Markowitz Wayne, CVP, JAPAC
No 10b5-1 planSold 0.7% of holdings ($1.9M position)21,534 shares left0.3x usual sizeFiling
- 3 Form 4 saleRoutineAug 11 +12 days
Sold 619 shares at $92.03 ($57k)
Lippis Daniel J., CVP, TAVR
10b5-1 planSold 1.5% of holdings ($3.7M position)40,034 shares left0.8x usual sizeFiling
- 4 Form 4 saleNo planAug 26 +15 days
Sold 1,240 shares at $91.47 ($113k)
Markowitz Wayne, CVP, JAPAC
No 10b5-1 planSold 5.8% of holdings ($2M position)20,294 shares left2.1x usual sizeFiling
- 5 Form 4 saleUnusualAug 26 same day
Sold 31,800 shares at $91.02 ($2.9M)
Chopra Daveen, CVP, TMTT, Surgical & IHFM
No 10b5-1 planSold 41.8% of holdings ($6.9M position)44,324 shares left18.2x usual sizeFiling
- 6 Form 4 saleNo planAug 28 +2 days
Sold 2,644 shares at $89.98 ($238k)
Bruls Annette, CVP, EMEACLA
No 10b5-1 planSold 12.8% of holdings ($1.9M position)17,984 shares leftFirst sale on recordFiling
- 7 Form 4 saleNo planAug 31 +3 days
Sold 544 shares at $91.06 ($50k)
Dahl Andrew M., SVP, Corporate Controller
No 10b5-1 planSold 3.5% of holdings ($1.4M position)14,868 shares leftFiling
- 8 Form 4 saleRoutineSep 11 +11 days
Sold 619 shares at $87.51 ($54k)
Lippis Daniel J., CVP, TAVR
10b5-1 planSold 1.5% of holdings ($3.6M position)40,034 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (newest 400 of 1,102)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Lippis Daniel J. | CVP, TAVR | Form 4 sale | 619 | $54k | 1.5% | Routine | SEC |
| Aug 31, 2026 | Dahl Andrew M. | SVP, Corporate Controller | Form 4 sale | 544 | $50k | 3.5% | No plan | SEC |
| Aug 28, 2026 | Bruls Annette | CVP, EMEACLA | Form 4 sale | 2,644 | $238k | 12.8% | No plan | SEC |
| Aug 26, 2026 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | Form 4 sale | 31,800 | $2.9M | 41.8% | Unusual | SEC |
| Aug 26, 2026 | Markowitz Wayne | CVP, JAPAC | Form 4 sale | 1,240 | $113k | 5.8% | No plan | SEC |
| Aug 11, 2026 | Lippis Daniel J. | CVP, TAVR | Form 4 sale | 619 | $57k | 1.5% | Routine | SEC |
| Jul 30, 2026 | Markowitz Wayne | CVP, JAPAC | Form 4 sale | 146 | $13k | 0.7% | No plan | SEC |
| Jul 28, 2026 | Markowitz Wayne | CVP, JAPAC | Form 4 sale | 9,628 | $819k | 30.8% | Unusual | SEC |
| Jul 27, 2026 | Zovighian Bernard J | CEO | Form 4 sale | 2,921 | $245k | 24.7% | No plan | SEC |
| Jul 10, 2026 | Lippis Daniel J. | CVP, TAVR | Form 4 sale | 619 | $57k | 1.5% | Routine | SEC |
| Jun 30, 2026 | Lippis Daniel J. | CVP, TAVR | Form 4 sale | 619 | $57k | 1.5% | Routine | SEC |
| Jun 17, 2026 | Zovighian Bernard J | CEO | Form 4 sale | 523 | $46k | 4.3% | Routine | SEC |
| May 29, 2026 | Dahl Andrew M. | SVP, Corporate Controller | Form 4 sale | 568 | $49k | 3.6% | No plan | SEC |
| May 27, 2026 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 23,145 | $2M | 19.0% | Unusual | SEC |
| May 22, 2026 | Chopra Daveen | CVP, TMTT & Surgical | Form 4 sale | 1,500 | $127k | 3.3% | No plan | SEC |
| May 18, 2026 | Lippis Daniel J. | CVP, TAVR | Form 4 sale | 620 | $50k | 1.5% | Routine | SEC |
| May 15, 2026 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 17,968 | $1.5M | 44.1% | Unusual | SEC |
| May 12, 2026 | Zovighian Bernard J | CEO | Form 4 sale | 36,351 | $2.8M | 75.1% | Routine | SEC |
| May 11, 2026 | Markowitz Wayne | CVP, JAPAC | Form 4 sale | 593 | $47k | 2.7% | No plan | SEC |
| May 4, 2026 | Lippis Daniel J. | CVP, TAVR | Form 4 sale | 2,038 | $170k | 5.7% | Routine | SEC |
| Apr 9, 2026 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 13,000 | $1M | 24.7% | Routine | SEC |
| Apr 6, 2026 | Lippis Daniel J. | CVP, TAVR | Form 4 sale | 1,019 | $83k | 2.9% | Routine | SEC |
| Apr 2, 2026 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 22,680 | $1.8M | 51.6% | Unusual | SEC |
| Mar 11, 2026 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 13,000 | $1.1M | 24.7% | Routine | SEC |
| Mar 11, 2026 | Lippis Daniel J. | CVP, TAVR | Form 4 sale | 1,019 | $87k | 2.9% | Routine | SEC |
| Mar 2, 2026 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,340 | $974k | 34.8% | Routine | SEC |
| Feb 25, 2026 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 24,000 | $2M | 53.0% | Unusual | SEC |
| Feb 12, 2026 | Zovighian Bernard J | CEO | Form 4 sale | 22,430 | $1.7M | 21.1% | No plan | SEC |
| Jan 9, 2026 | Lippis Daniel J. | CVP, TAVR | Form 4 sale | 1,019 | $87k | 4.4% | Routine | SEC |
| Jan 6, 2026 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,340 | $971k | 26.2% | Routine | SEC |
| Dec 12, 2025 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,386 | $954k | 22.6% | No plan | SEC |
| Dec 12, 2025 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 1,019 | $86k | 4.4% | Routine | SEC |
| Dec 12, 2025 | Stone Heisz Leslie | Director | Form 4 sale | 2,615 | $218k | 7.8% | No plan | SEC |
| Dec 11, 2025 | Chopra Daveen | CVP, TMTT & Surgical | Form 4 sale | 2,000 | $169k | 5.8% | No plan | SEC |
| Dec 10, 2025 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,340 | $951k | 18.4% | Routine | SEC |
| Dec 10, 2025 | Zovighian Bernard J | CEO | Form 4 sale | 25,350 | $2.2M | 23.0% | Unusual | SEC |
| Dec 9, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 7,700 | $650k | 16.2% | Routine | SEC |
| Dec 8, 2025 | Markowitz Wayne | CVP, JAPAC | Form 4 sale | 583 | $50k | 3.2% | No plan | SEC |
| Nov 10, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 13,000 | $1.1M | 24.6% | Routine | SEC |
| Nov 10, 2025 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 1,020 | $84k | 4.4% | Routine | SEC |
| Aug 25, 2025 | Chopra Daveen | CVP, TMTT | Form 4 sale | 2,500 | $205k | 7.5% | No plan | SEC |
| Aug 18, 2025 | Wood Larry L | Global President TAVR & Surg | Form 4 sale | 8,950 | $699k | 4.1% | Routine | SEC |
| Jul 28, 2025 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 4,114 | $327k | 15.8% | Unusual | SEC |
| Jun 16, 2025 | Wood Larry L | Global President TAVR & Surg | Form 4 sale | 8,950 | $673k | 4.1% | Routine | SEC |
| Jun 3, 2025 | Zovighian Bernard J | CEO | Form 4 sale | 17,066 | $1.3M | 66.5% | Routine | SEC |
| Jun 2, 2025 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 2,570 | $199k | 4.9% | Routine | SEC |
| May 22, 2025 | Chopra Daveen | CVP, TMTT | Form 4 sale | 1,500 | $113k | 4.3% | No plan | SEC |
| May 9, 2025 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 330 | $25k | 1.2% | Routine | SEC |
| May 9, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 11,250 | $837k | 21.5% | Routine | SEC |
| May 7, 2025 | Markowitz Wayne | GM & SVP, Surgical | Form 4 sale | 268 | $20k | 2.8% | No plan | SEC |
| May 5, 2025 | Zovighian Bernard J | CEO | Form 4 sale | 5,980 | $448k | 9.3% | Routine | SEC |
| Apr 14, 2025 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 9,500 | $663k | 16.8% | Routine | SEC |
| Apr 8, 2025 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 300 | $21k | 1.3% | Routine | SEC |
| Mar 26, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 11,250 | $797k | 27.0% | Routine | SEC |
| Mar 13, 2025 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 9,500 | $646k | 16.8% | Routine | SEC |
| Mar 10, 2025 | Zovighian Bernard J | CEO | Form 4 sale | 6,164 | $428k | 9.4% | Routine | SEC |
| Mar 10, 2025 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 400 | $28k | 1.7% | Routine | SEC |
| Feb 28, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 11,250 | $796k | 27.0% | Routine | SEC |
| Feb 14, 2025 | Loranger Steven R | Director | Form 4 sale | 5,739 | $439k | 8.7% | No plan | SEC |
| Feb 13, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 11,250 | $852k | 26.9% | Routine | SEC |
| Feb 13, 2025 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,500 | $492k | 12.2% | Routine | SEC |
| Feb 13, 2025 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 500 | $38k | 2.1% | Routine | SEC |
| Feb 13, 2025 | Stone Heisz Leslie | Director | Form 4 sale | 5,739 | $435k | 16.0% | No plan | SEC |
| Jan 16, 2025 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 500 | $34k | 2.1% | Routine | SEC |
| Jan 16, 2025 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,000 | $344k | 9.6% | Routine | SEC |
| Dec 16, 2024 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 2,500 | $185k | 9.7% | Routine | SEC |
| Dec 16, 2024 | Lippis Daniel J. | Officer | Form 144 notice | 2,500 | $185k | Notice | SEC | |
| Dec 9, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 11,250 | $806k | 26.9% | Routine | SEC |
| Dec 9, 2024 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,000 | $359k | 9.6% | Routine | SEC |
| Dec 9, 2024 | Ullem Scott B. | Officer | Form 144 notice | 33,750 | $2.4M | Notice | SEC | |
| Dec 6, 2024 | Chopra Daveen | CVP, TMTT | Form 4 sale | 1,750 | $128k | 6.0% | No plan | SEC |
| Dec 6, 2024 | Markowitz Wayne | GM & SVP, Surgical | Form 4 sale | 583 | $43k | 5.8% | No plan | SEC |
| Dec 6, 2024 | Markowitz Wayne | Officer | Form 144 notice | 583 | $43k | Notice | SEC | |
| Dec 6, 2024 | Chopra Daveen | Officer | Form 144 notice | 1,750 | $128k | Notice | SEC | |
| Nov 13, 2024 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,000 | $328k | 9.6% | Routine | SEC |
| Nov 5, 2024 | Wood Larry L | Global President TAVR & Surg | Form 4 sale | 25,000 | $1.6M | 11.2% | Routine | SEC |
| Oct 15, 2024 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,000 | $348k | 9.6% | Routine | SEC |
| Sep 11, 2024 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,000 | $334k | 9.6% | Routine | SEC |
| Aug 20, 2024 | Chopra Daveen | CVP, TMTT | Form 4 sale | 1,250 | $87k | 4.1% | No plan | SEC |
| Aug 14, 2024 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,000 | $330k | 9.6% | Routine | SEC |
| Jul 11, 2024 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 500 | $47k | 2.1% | Routine | SEC |
| Jul 10, 2024 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,000 | $466k | 9.6% | Routine | SEC |
| Jun 20, 2024 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 535 | $48k | 2.2% | Routine | SEC |
| Jun 20, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 5,625 | $492k | 15.5% | Routine | SEC |
| Jun 12, 2024 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,000 | $438k | 9.6% | Routine | SEC |
| May 30, 2024 | Zovighian Bernard J | CEO | Form 4 sale | 8,617 | $756k | 11.2% | Routine | SEC |
| May 21, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 5,625 | $509k | 15.5% | Routine | SEC |
| May 10, 2024 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,000 | $439k | 9.5% | Routine | SEC |
| May 7, 2024 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 857 | $73k | 3.5% | Routine | SEC |
| May 2, 2024 | Mussallem Michael A | Director | Form 4 sale | 29,350 | $2.5M | 86.7% | Routine | SEC |
| May 1, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | Form 4 sale | 14,400 | $1.2M | 7.6% | Routine | SEC |
| Apr 30, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 7,250 | $622k | 27.5% | Routine | SEC |
| Apr 9, 2024 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 857 | $79k | 4.7% | Routine | SEC |
| Apr 8, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA | Form 4 sale | 14,400 | $1.3M | 7.6% | Routine | SEC |
| Apr 8, 2024 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 12,500 | $1.2M | 23.9% | Routine | SEC |
| Apr 4, 2024 | Mussallem Michael A | Director | Form 4 sale | 29,350 | $2.7M | 86.7% | Routine | SEC |
| Apr 1, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 7,255 | $688k | 27.6% | Routine | SEC |
| Mar 13, 2024 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 14,500 | $1.3M | 26.9% | Routine | SEC |
| Mar 11, 2024 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | Form 4 sale | 14,400 | $1.3M | 7.7% | Routine | SEC |
| Mar 7, 2024 | Lippis Daniel J. | CVP, JAPAC | Form 4 sale | 1,715 | $156k | 9.1% | Routine | SEC |
| Mar 4, 2024 | Mussallem Michael A | Director | Form 4 sale | 29,350 | $2.5M | 86.7% | Routine | SEC |
| Feb 29, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 7,255 | $621k | 27.6% | Routine | SEC |
| Feb 23, 2024 | Gallahue Kieran | Director | Form 4 sale | 3,058 | $268k | 4.4% | No plan | SEC |
| Feb 21, 2024 | Chopra Daveen | CVP, TMTT | Form 4 sale | 8,200 | $711k | 26.5% | Unusual | SEC |
| Feb 15, 2024 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 47,000 | $4M | 57.4% | Unusual | SEC |
| Feb 13, 2024 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,000 | $944k | 21.8% | Routine | SEC |
| Feb 12, 2024 | Sellers Robert W.A. | SVP, Corporate Controller | Form 4 sale | 12,210 | $1.1M | 48.3% | Unusual | SEC |
| Feb 8, 2024 | Stone Heisz Leslie | Director | Form 4 sale | 7,056 | $610k | 20.7% | No plan | SEC |
| Feb 5, 2024 | Mussallem Michael A | Director | Form 4 sale | 29,350 | $2.6M | 86.7% | Routine | SEC |
| Feb 1, 2024 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 7,255 | $568k | 27.4% | Routine | SEC |
| Jan 12, 2024 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 10,000 | $757k | 20.2% | Routine | SEC |
| Jan 5, 2024 | Mussallem Michael A | Director | Form 4 sale | 29,350 | $2.1M | 86.7% | Routine | SEC |
| Dec 29, 2023 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 14,510 | $1.1M | 43.0% | Routine | SEC |
| Dec 15, 2023 | Chopra Daveen | Officer | Form 144 notice | 7,000 | $548k | Notice | SEC | |
| Dec 15, 2023 | Chopra Daveen | CVP, TMTT | Form 4 sale | 7,000 | $548k | 22.6% | No plan | SEC |
| Dec 13, 2023 | Mussallem Michael A | Other: Former CEO | Form 144 notice | 88,050 | $6.6M | Notice | SEC | |
| Dec 13, 2023 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 8,000 | $575k | 16.8% | Routine | SEC |
| Dec 13, 2023 | Wood Larry L | Global President TAVR & Surg | Form 4 sale | 8,658 | $622k | 3.9% | Routine | SEC |
| Dec 13, 2023 | Mussallem Michael A | Director | Form 4 sale | 29,350 | $2.2M | 86.7% | Routine | SEC |
| Dec 6, 2023 | Chopra Daveen | CVP, TMTT | Form 4 sale | 3,500 | $245k | 12.8% | Routine | SEC |
| Dec 6, 2023 | Chopra Daveen | Officer | Form 144 notice | 3,500 | $245k | Notice | SEC | |
| Nov 13, 2023 | Bobo Donald E Jr | Officer | Form 144 notice | 24,000 | $392k | Notice | SEC | |
| Nov 13, 2023 | Wood Larry L | Global President TAVR & Surg | Form 4 sale | 8,660 | $565k | 3.9% | Routine | SEC |
| Nov 13, 2023 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,000 | $392k | 13.2% | Routine | SEC |
| Nov 3, 2023 | Mussallem Michael A | Director | Form 4 sale | 29,350 | $2M | 86.7% | Routine | SEC |
| Oct 31, 2023 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 7,255 | $455k | 27.4% | Routine | SEC |
| Oct 13, 2023 | Wood Larry L | Global President TAVR & Surg | Form 4 sale | 8,660 | $606k | 3.9% | Routine | SEC |
| Oct 13, 2023 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,000 | $350k | 11.2% | Routine | SEC |
| Oct 10, 2023 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 5,000 | $363k | 12.6% | Routine | SEC |
| Oct 3, 2023 | Chopra Daveen | CVP, TMTT | Form 4 sale | 8,500 | $595k | 26.2% | Routine | SEC |
| Oct 2, 2023 | Mussallem Michael A | Director | Form 4 sale | 29,350 | $2M | 86.7% | Routine | SEC |
| Sep 29, 2023 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 7,255 | $505k | 27.4% | Routine | SEC |
| Sep 14, 2023 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 4,500 | $332k | 10.2% | Routine | SEC |
| Sep 14, 2023 | Wood Larry L | Global President TAVR & Surg | Form 4 sale | 8,660 | $638k | 3.9% | Routine | SEC |
| Sep 14, 2023 | Wood Larry L | Officer | Form 144 notice | 34,638 | $2.6M | Notice | SEC | |
| Sep 8, 2023 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 5,000 | $380k | 12.6% | Routine | SEC |
| Sep 6, 2023 | Chopra Daveen | Officer | Form 144 notice | 20,500 | $1.6M | Notice | SEC | |
| Sep 6, 2023 | Chopra Daveen | CVP, TMTT | Form 4 sale | 8,500 | $647k | 26.2% | Routine | SEC |
| Sep 5, 2023 | Mussallem Michael A | Other: Former CEO | Form 144 notice | 88,050 | $6.7M | Notice | SEC | |
| Sep 5, 2023 | Mussallem Michael A | Director | Form 4 sale | 29,350 | $2.2M | 86.7% | Routine | SEC |
| Aug 31, 2023 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 7,255 | $564k | 27.4% | Routine | SEC |
| Aug 31, 2023 | Ullem Scott B. | Officer | Form 144 notice | 21,765 | $1.7M | Notice | SEC | |
| Aug 29, 2023 | Chopra Daveen | CVP, TMTT | Form 4 sale | 1,500 | $115k | 5.9% | No plan | SEC |
| Aug 29, 2023 | Chopra Daveen | Officer | Form 144 notice | 1,500 | $115k | Notice | SEC | |
| Aug 14, 2023 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 4,500 | $357k | 10.2% | Routine | SEC |
| Aug 14, 2023 | Wood Larry L | Global President TAVR & Surg | Form 4 sale | 6,421 | $509k | 2.9% | Routine | SEC |
| Aug 14, 2023 | Bobo Donald E Jr | Officer | Form 144 notice | 14,000 | $1.1M | Notice | SEC | |
| Aug 10, 2023 | Stone Heisz Leslie | Director | Form 4 sale | 3,303 | $261k | 10.9% | No plan | SEC |
| Aug 10, 2023 | Stone Heisz Leslie | Director | Form 144 notice | 3,303 | $261k | Notice | SEC | |
| Aug 9, 2023 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 5,000 | $393k | 12.6% | Routine | SEC |
| Aug 9, 2023 | Szyman Catherine M. | Officer | Form 144 notice | 15,000 | $1.2M | Notice | SEC | |
| Aug 7, 2023 | Mussallem Michael A | Director | Form 4 sale | 29,350 | $2.3M | 35.1% | Routine | SEC |
| Jul 31, 2023 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 7,255 | $612k | 27.4% | Routine | SEC |
| Jul 14, 2023 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 3,500 | $325k | 8.1% | Routine | SEC |
| Jul 14, 2023 | Wood Larry L | Global President TAVR & Surg | Form 4 sale | 8,660 | $805k | 3.9% | Routine | SEC |
| Jul 10, 2023 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 5,000 | $453k | 12.6% | Routine | SEC |
| Jul 5, 2023 | Mussallem Michael A | Director | Form 4 sale | 29,350 | $2.7M | 35.1% | Routine | SEC |
| Jun 30, 2023 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 7,255 | $677k | 27.4% | Routine | SEC |
| Jun 14, 2023 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 3,500 | $314k | 8.1% | Routine | SEC |
| Jun 14, 2023 | Wood Larry L | Global President TAVR & Surg | Form 4 sale | 8,660 | $781k | 3.9% | Routine | SEC |
| Jun 13, 2023 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 5,000 | $429k | 12.5% | Routine | SEC |
| Jun 1, 2023 | Mussallem Michael A | Other: Chairman & CEO | Form 144 notice | 88,050 | $7.5M | Notice | SEC | |
| Jun 1, 2023 | Mussallem Michael A | Director | Form 4 sale | 29,350 | $2.5M | 25.4% | Routine | SEC |
| May 24, 2023 | Wood Larry L | Global President TAVR & Surg | Form 4 sale | 6,421 | $541k | 2.9% | Routine | SEC |
| May 24, 2023 | Wood Larry L | Officer | Form 144 notice | 30,162 | $2.5M | Notice | SEC | |
| May 10, 2023 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 2,500 | $223k | 7.0% | Routine | SEC |
| May 10, 2023 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 80,700 | $7.1M | 81.5% | Routine | SEC |
| May 10, 2023 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 19,875 | $1.8M | 19.6% | Routine | SEC |
| May 10, 2023 | Bobo Donald E Jr | Officer | Form 144 notice | 9,500 | $848k | Notice | SEC | |
| May 10, 2023 | Ullem Scott B. | Officer | Form 144 notice | 95,210 | $8.4M | Notice | SEC | |
| May 9, 2023 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | Form 4 sale | 6,640 | $589k | 3.7% | Routine | SEC |
| May 9, 2023 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 75,600 | $6.7M | 72.6% | Unusual | SEC |
| May 9, 2023 | Szyman Catherine M. | Officer | Form 144 notice | 85,600 | $7.6M | Notice | SEC | |
| May 5, 2023 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,635 | $499k | 9.1% | No plan | SEC |
| May 5, 2023 | Bobo Donald E Jr | Officer, Director | Form 144 notice | 5,635 | $499k | Notice | SEC | |
| Apr 28, 2023 | Sellers Robert W.A. | SVP, Corporate Controller | Form 4 sale | 12,270 | $1.1M | 51.1% | Unusual | SEC |
| Apr 28, 2023 | Sellers Robert W.A. | Officer | Form 144 notice | 12,270 | $1.1M | Notice | SEC | |
| Apr 14, 2023 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 19,875 | $1.7M | 24.6% | Routine | SEC |
| Apr 14, 2023 | Mussallem Michael A | Other: Chairman & CEO | Form 144 notice | 39,750 | $3.4M | Notice | SEC | |
| Apr 6, 2023 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,725 | $559k | 9.7% | Routine | SEC |
| Apr 6, 2023 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | Form 4 sale | 6,640 | $552k | 3.8% | Routine | SEC |
| Mar 15, 2023 | Chopra Daveen | CVP, TMTT | Form 4 sale | 4,435 | $344k | 19.0% | Plan not stated | SEC |
| Mar 14, 2023 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 19,875 | $1.5M | 24.6% | Plan not stated | SEC |
| Mar 8, 2023 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | Form 4 sale | 6,640 | $511k | 3.8% | Plan not stated | SEC |
| Mar 8, 2023 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,725 | $518k | 9.7% | Plan not stated | SEC |
| Feb 16, 2023 | Stone Heisz Leslie | Director | Form 4 sale | 9,671 | $743k | 26.0% | Unusual | SEC |
| Feb 15, 2023 | Chopra Daveen | CVP, TMTT | Form 4 sale | 4,000 | $304k | 17.5% | Plan not stated | SEC |
| Feb 14, 2023 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 19,875 | $1.5M | 11.2% | Plan not stated | SEC |
| Feb 6, 2023 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,725 | $543k | 9.7% | Plan not stated | SEC |
| Jan 17, 2023 | Chopra Daveen | CVP, TMTT | Form 4 sale | 4,000 | $312k | 17.5% | Plan not stated | SEC |
| Jan 13, 2023 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 19,875 | $1.6M | 11.2% | Plan not stated | SEC |
| Jan 9, 2023 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,725 | $521k | 9.7% | Plan not stated | SEC |
| Dec 15, 2022 | Chopra Daveen | CVP, Surgical Structural Heart | Form 4 sale | 4,000 | $299k | 17.5% | Plan not stated | SEC |
| Dec 14, 2022 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 19,875 | $1.5M | 11.2% | Plan not stated | SEC |
| Dec 13, 2022 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,236 | $557k | 3.5% | Plan not stated | SEC |
| Dec 12, 2022 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,725 | $500k | 9.7% | Plan not stated | SEC |
| Nov 15, 2022 | Chopra Daveen | CVP, Surgical Structural Heart | Form 4 sale | 4,000 | $297k | 17.5% | Plan not stated | SEC |
| Nov 14, 2022 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 19,875 | $1.5M | 11.2% | Plan not stated | SEC |
| Nov 8, 2022 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,725 | $460k | 9.7% | Plan not stated | SEC |
| Nov 8, 2022 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,242 | $496k | 3.5% | Plan not stated | SEC |
| Oct 14, 2022 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 19,875 | $1.6M | 11.2% | Plan not stated | SEC |
| Oct 14, 2022 | Chopra Daveen | CVP, Surgical Structural Heart | Form 4 sale | 4,000 | $339k | 17.5% | Unusual | SEC |
| Oct 11, 2022 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,242 | $595k | 3.5% | Plan not stated | SEC |
| Oct 10, 2022 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,725 | $572k | 9.7% | Plan not stated | SEC |
| Sep 22, 2022 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 19,875 | $1.7M | 11.2% | Plan not stated | SEC |
| Sep 8, 2022 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,725 | $612k | 9.7% | Plan not stated | SEC |
| Sep 6, 2022 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,242 | $645k | 3.5% | Plan not stated | SEC |
| Aug 15, 2022 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 19,875 | $2.1M | 11.2% | Plan not stated | SEC |
| Aug 9, 2022 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,725 | $706k | 9.7% | Plan not stated | SEC |
| Aug 9, 2022 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,242 | $758k | 3.5% | Plan not stated | SEC |
| Aug 5, 2022 | Zovighian Bernard J | CVP, TMTT | Form 4 sale | 4,811 | $499k | 18.5% | Plan not stated | SEC |
| Aug 2, 2022 | Chopra Daveen | CVP, Surgical Structural Heart | Form 4 sale | 1,000 | $102k | 5.0% | Plan not stated | SEC |
| Jul 14, 2022 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 19,875 | $1.9M | 10.6% | Plan not stated | SEC |
| Jul 8, 2022 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,725 | $656k | 9.7% | Plan not stated | SEC |
| Jul 8, 2022 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 3,675 | $359k | 3.6% | Plan not stated | SEC |
| Jul 5, 2022 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,242 | $695k | 3.5% | Plan not stated | SEC |
| Jun 14, 2022 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 19,875 | $1.7M | 11.2% | Plan not stated | SEC |
| Jun 14, 2022 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 3,675 | $322k | 3.6% | Plan not stated | SEC |
| Jun 14, 2022 | Zovighian Bernard J | CVP, TMTT | Form 4 sale | 4,809 | $422k | 15.6% | Plan not stated | SEC |
| Jun 13, 2022 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,725 | $605k | 9.7% | Plan not stated | SEC |
| Jun 1, 2022 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,242 | $728k | 3.5% | Plan not stated | SEC |
| May 31, 2022 | Zovighian Bernard J | CVP, TMTT | Form 4 sale | 9,000 | $907k | 22.6% | Plan not stated | SEC |
| May 26, 2022 | Chopra Daveen | CVP, Surgical Structural Heart | Form 4 sale | 1,000 | $98k | 4.8% | Plan not stated | SEC |
| May 24, 2022 | Zovighian Bernard J | CVP, TMTT | Form 4 sale | 4,809 | $459k | 10.8% | Plan not stated | SEC |
| May 10, 2022 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 32,550 | $3.1M | 17.1% | Plan not stated | SEC |
| May 10, 2022 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,242 | $696k | 3.4% | Plan not stated | SEC |
| May 9, 2022 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 6,725 | $664k | 9.5% | Plan not stated | SEC |
| May 9, 2022 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 3,675 | $363k | 3.5% | Plan not stated | SEC |
| May 9, 2022 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Form 4 sale | 11,560 | $1.1M | 6.6% | Plan not stated | SEC |
| May 4, 2022 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 23,400 | $2.5M | 43.1% | Unusual | SEC |
| Apr 29, 2022 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 32,550 | $3.5M | 26.2% | Unusual | SEC |
| Apr 28, 2022 | Marsh Martha H. | Director | Form 4 sale | 28,722 | $3.1M | 51.8% | Unusual | SEC |
| Apr 11, 2022 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 20,000 | $2.4M | 42.0% | Unusual | SEC |
| Apr 8, 2022 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Form 4 sale | 11,660 | $1.4M | 7.1% | Plan not stated | SEC |
| Apr 8, 2022 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,050 | $1.4M | 16.3% | Plan not stated | SEC |
| Apr 8, 2022 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 3,675 | $452k | 3.6% | Plan not stated | SEC |
| Apr 5, 2022 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,242 | $877k | 3.5% | Plan not stated | SEC |
| Mar 22, 2022 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 32,550 | $3.7M | 29.1% | Unusual | SEC |
| Mar 14, 2022 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 20,000 | $2.1M | 42.2% | Unusual | SEC |
| Mar 11, 2022 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,050 | $1.2M | 16.4% | Plan not stated | SEC |
| Mar 11, 2022 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Form 4 sale | 11,660 | $1.2M | 7.1% | Plan not stated | SEC |
| Mar 8, 2022 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 3,675 | $395k | 3.6% | Plan not stated | SEC |
| Mar 8, 2022 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,242 | $772k | 3.5% | Plan not stated | SEC |
| Feb 18, 2022 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 20,000 | $2.1M | 42.2% | Unusual | SEC |
| Feb 15, 2022 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 32,550 | $3.6M | 29.1% | Unusual | SEC |
| Feb 11, 2022 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,050 | $1.2M | 16.4% | Plan not stated | SEC |
| Feb 8, 2022 | Gallahue Kieran | Director | Form 4 sale | 32,256 | $3.6M | 90.4% | Unusual | SEC |
| Feb 8, 2022 | Wood Larry L | CVP, TAVR | Form 4 sale | 4,386 | $480k | 2.2% | Plan not stated | SEC |
| Feb 8, 2022 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 6,350 | $700k | 6.1% | Plan not stated | SEC |
| Jan 28, 2022 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,050 | $1.1M | 16.1% | Plan not stated | SEC |
| Jan 14, 2022 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 10,000 | $1.2M | 26.7% | Unusual | SEC |
| Jan 7, 2022 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 6,350 | $776k | 6.1% | Plan not stated | SEC |
| Jan 6, 2022 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 32,550 | $4M | 14.8% | Plan not stated | SEC |
| Dec 20, 2021 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 32,550 | $3.9M | 14.8% | Plan not stated | SEC |
| Dec 17, 2021 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 10,000 | $1.2M | 26.7% | Unusual | SEC |
| Dec 10, 2021 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,830 | $951k | 3.8% | Plan not stated | SEC |
| Dec 10, 2021 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,050 | $1.3M | 16.4% | Plan not stated | SEC |
| Dec 10, 2021 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 6,350 | $772k | 6.1% | Plan not stated | SEC |
| Nov 29, 2021 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Form 4 sale | 100 | $11k | 0.1% | Plan not stated | SEC |
| Nov 18, 2021 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 10,000 | $1.2M | 26.7% | Unusual | SEC |
| Nov 10, 2021 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,830 | $938k | 2.1% | Plan not stated | SEC |
| Nov 9, 2021 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 32,550 | $3.9M | 14.8% | Plan not stated | SEC |
| Nov 8, 2021 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 6,350 | $758k | 6.1% | Plan not stated | SEC |
| Nov 5, 2021 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,050 | $1.3M | 16.4% | Plan not stated | SEC |
| Oct 18, 2021 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 9,741 | $1.1M | 26.2% | Unusual | SEC |
| Oct 11, 2021 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,830 | $846k | 2.1% | Plan not stated | SEC |
| Oct 8, 2021 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,050 | $1.2M | 16.4% | Plan not stated | SEC |
| Oct 8, 2021 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 6,350 | $704k | 6.1% | Plan not stated | SEC |
| Oct 1, 2021 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 32,550 | $3.6M | 14.8% | Plan not stated | SEC |
| Sep 15, 2021 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 32,550 | $3.9M | 14.8% | Plan not stated | SEC |
| Sep 10, 2021 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,050 | $1.4M | 16.4% | Plan not stated | SEC |
| Sep 10, 2021 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,830 | $960k | 2.1% | Plan not stated | SEC |
| Sep 8, 2021 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 6,350 | $770k | 6.1% | Plan not stated | SEC |
| Sep 8, 2021 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 9,741 | $1.2M | 26.2% | Unusual | SEC |
| Aug 10, 2021 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,830 | $894k | 2.1% | Plan not stated | SEC |
| Aug 9, 2021 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 6,350 | $734k | 6.1% | Plan not stated | SEC |
| Aug 6, 2021 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,050 | $1.3M | 16.4% | Plan not stated | SEC |
| Aug 3, 2021 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 32,550 | $3.7M | 14.8% | Plan not stated | SEC |
| Aug 2, 2021 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 15,000 | $1.7M | 35.1% | Unusual | SEC |
| Jul 12, 2021 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,830 | $842k | 2.1% | Plan not stated | SEC |
| Jul 9, 2021 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,050 | $1.2M | 16.4% | Plan not stated | SEC |
| Jul 8, 2021 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 6,350 | $678k | 6.1% | Plan not stated | SEC |
| Jul 1, 2021 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 32,550 | $3.4M | 14.8% | Plan not stated | SEC |
| Jun 15, 2021 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 3,410 | $345k | 11.0% | Plan not stated | SEC |
| Jun 15, 2021 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 6,350 | $641k | 6.1% | Plan not stated | SEC |
| Jun 14, 2021 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,830 | $782k | 2.1% | Plan not stated | SEC |
| Jun 14, 2021 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,050 | $1.1M | 16.4% | Plan not stated | SEC |
| Jun 14, 2021 | Chopra Daveen | CVP, Surgical Structural Heart | Form 4 sale | 24,000 | $2.4M | 60.3% | Unusual | SEC |
| Jun 9, 2021 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 32,550 | $3.2M | 14.8% | Plan not stated | SEC |
| May 28, 2021 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 2,061 | $196k | 6.9% | Plan not stated | SEC |
| May 25, 2021 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 4,665 | $448k | 13.5% | Plan not stated | SEC |
| May 24, 2021 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 33,000 | $3.2M | 14.9% | Plan not stated | SEC |
| May 10, 2021 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,830 | $722k | 2.1% | Plan not stated | SEC |
| May 7, 2021 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 11,050 | $1M | 17.3% | Plan not stated | SEC |
| May 7, 2021 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 3,389 | $311k | 9.9% | Plan not stated | SEC |
| May 7, 2021 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 6,350 | $583k | 6.2% | Plan not stated | SEC |
| May 5, 2021 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 35,550 | $3.3M | 26.8% | Unusual | SEC |
| Apr 23, 2021 | Sellers Robert W.A. | VP, Corporate Controller | Form 4 sale | 12,000 | $1.2M | 37.0% | Unusual | SEC |
| Apr 23, 2021 | Stone Heisz Leslie | Director | Form 4 sale | 6,707 | $654k | 22.9% | Plan not stated | SEC |
| Apr 22, 2021 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 3,389 | $320k | 11.2% | Plan not stated | SEC |
| Apr 12, 2021 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,830 | $672k | 2.1% | Plan not stated | SEC |
| Apr 9, 2021 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 13,077 | $1.1M | 21.1% | Plan not stated | SEC |
| Apr 8, 2021 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 68,550 | $5.8M | 24.5% | Plan not stated | SEC |
| Apr 8, 2021 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 6,350 | $539k | 6.4% | Plan not stated | SEC |
| Apr 1, 2021 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Form 4 sale | 13,020 | $1.1M | 8.5% | Unusual | SEC |
| Mar 15, 2021 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 3,389 | $277k | 11.2% | Plan not stated | SEC |
| Mar 12, 2021 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 13,077 | $1.1M | 21.2% | Plan not stated | SEC |
| Mar 9, 2021 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 68,550 | $5.7M | 24.5% | Unusual | SEC |
| Mar 8, 2021 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 6,350 | $517k | 6.4% | Plan not stated | SEC |
| Mar 1, 2021 | Wood Larry L | CVP, TAVR | Form 4 sale | 7,830 | $658k | 2.1% | Plan not stated | SEC |
| Mar 1, 2021 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Form 4 sale | 13,020 | $1.1M | 8.6% | Unusual | SEC |
| Feb 23, 2021 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 68,550 | $5.8M | 22.1% | Unusual | SEC |
| Feb 16, 2021 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 3,389 | $299k | 11.2% | Plan not stated | SEC |
| Feb 11, 2021 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 11,745 | $1M | 11.2% | Plan not stated | SEC |
| Feb 5, 2021 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 13,077 | $1.1M | 21.2% | Plan not stated | SEC |
| Feb 4, 2021 | Valeriani Nicholas J | Director | Form 4 sale | 8,200 | $699k | 12.1% | Plan not stated | SEC |
| Feb 1, 2021 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Form 4 sale | 20,523 | $1.7M | 12.8% | Unusual | SEC |
| Jan 15, 2021 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 68,550 | $6M | 24.5% | Unusual | SEC |
| Jan 15, 2021 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 11,730 | $1M | 11.2% | Plan not stated | SEC |
| Jan 15, 2021 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 3,389 | $296k | 11.2% | Plan not stated | SEC |
| Jan 8, 2021 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 13,077 | $1.2M | 21.2% | Plan not stated | SEC |
| Jan 4, 2021 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Form 4 sale | 20,523 | $1.9M | 12.8% | Unusual | SEC |
| Dec 15, 2020 | Wood Larry L | CVP, TAVR | Form 4 sale | 10,722 | $903k | 2.9% | Plan not stated | SEC |
| Dec 14, 2020 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 68,550 | $5.8M | 22.1% | Plan not stated | SEC |
| Dec 14, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 11,733 | $992k | 11.2% | Plan not stated | SEC |
| Dec 11, 2020 | Name not stated | CVP,Strategy/Corp Development | Form 4 sale | 13,074 | $1.1M | 21.2% | Plan not stated | SEC |
| Nov 17, 2020 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 68,550 | $5.8M | 24.5% | Plan not stated | SEC |
| Nov 13, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 13,074 | $1.1M | 21.2% | Plan not stated | SEC |
| Nov 11, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 11,730 | $953k | 11.2% | Plan not stated | SEC |
| Nov 9, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 574 | $46k | 58.7% | Unusual | SEC |
| Nov 2, 2020 | Wood Larry L | CVP, TAVR | Form 4 sale | 10,698 | $784k | 2.9% | Plan not stated | SEC |
| Oct 29, 2020 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 20,355 | $1.5M | 43.2% | Unusual | SEC |
| Oct 26, 2020 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 33,150 | $2.6M | 55.0% | Unusual | SEC |
| Oct 12, 2020 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 33,150 | $2.8M | 55.0% | Unusual | SEC |
| Oct 9, 2020 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 68,550 | $5.7M | 22.1% | Plan not stated | SEC |
| Oct 9, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 11,733 | $969k | 11.1% | Plan not stated | SEC |
| Oct 9, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 13,074 | $1.1M | 21.2% | Plan not stated | SEC |
| Oct 1, 2020 | Wood Larry L | CVP, TAVR | Form 4 sale | 10,698 | $860k | 2.9% | Plan not stated | SEC |
| Sep 29, 2020 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 68,550 | $5.4M | 22.1% | Unusual | SEC |
| Sep 28, 2020 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 33,150 | $2.6M | 55.0% | Unusual | SEC |
| Sep 15, 2020 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 33,150 | $2.8M | 55.0% | Unusual | SEC |
| Sep 14, 2020 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 26,700 | $2.2M | 49.6% | Unusual | SEC |
| Sep 11, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 13,074 | $1.1M | 21.2% | Plan not stated | SEC |
| Sep 11, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 11,730 | $967k | 11.1% | Plan not stated | SEC |
| Sep 1, 2020 | Wood Larry L | CVP, TAVR | Form 4 sale | 10,698 | $910k | 2.9% | Plan not stated | SEC |
| Aug 28, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 7,200 | $607k | 5.5% | Plan not stated | SEC |
| Aug 27, 2020 | Sellers Robert W.A. | VP, Corporate Controller | Form 4 sale | 21,540 | $1.8M | 33.9% | Unusual | SEC |
| Aug 19, 2020 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 68,550 | $5.4M | 22.1% | Unusual | SEC |
| Aug 14, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 13,074 | $1M | 21.2% | Plan not stated | SEC |
| Aug 13, 2020 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 2,249 | $176k | 7.8% | Plan not stated | SEC |
| Aug 11, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 11,733 | $892k | 11.1% | Plan not stated | SEC |
| Aug 6, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 12,000 | $927k | 9.7% | Plan not stated | SEC |
| Aug 6, 2020 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 26,700 | $2.1M | 49.6% | Unusual | SEC |
| Aug 3, 2020 | Wood Larry L | CVP, TAVR | Form 4 sale | 10,698 | $839k | 2.9% | Plan not stated | SEC |
| Jul 14, 2020 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 2,249 | $152k | 7.2% | Plan not stated | SEC |
| Jul 10, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 11,649 | $786k | 11.0% | Plan not stated | SEC |
| Jul 10, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 13,074 | $882k | 15.2% | Plan not stated | SEC |
| Jul 9, 2020 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 68,550 | $4.7M | 22.1% | Plan not stated | SEC |
| Jul 6, 2020 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 26,700 | $1.9M | 49.6% | Unusual | SEC |
| Jul 6, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 591 | $41k | 0.6% | Plan not stated | SEC |
| Jul 1, 2020 | Wood Larry L | CVP, TAVR | Form 4 sale | 10,698 | $737k | 2.9% | Plan not stated | SEC |
| Jun 22, 2020 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 26,700 | $1.9M | 49.6% | Unusual | SEC |
| Jun 16, 2020 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 3,348 | $237k | 9.7% | Plan not stated | SEC |
| Jun 15, 2020 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 68,550 | $4.7M | 22.1% | Unusual | SEC |
| Jun 12, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 13,074 | $913k | 15.2% | Plan not stated | SEC |
| Jun 11, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 11,733 | $840k | 11.1% | Plan not stated | SEC |
| Jun 11, 2020 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 2,249 | $163k | 6.1% | Plan not stated | SEC |
| Jun 1, 2020 | Wood Larry L | CVP, TAVR | Form 4 sale | 10,698 | $806k | 2.9% | Plan not stated | SEC |
| May 18, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 1,717 | $372k | 5.2% | Plan not stated | SEC |
| May 15, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 4,358 | $938k | 15.2% | Plan not stated | SEC |
| May 14, 2020 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 1,116 | $237k | 8.3% | Plan not stated | SEC |
| May 13, 2020 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 750 | $163k | 5.3% | Plan not stated | SEC |
| May 11, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 3,883 | $850k | 10.8% | Plan not stated | SEC |
| May 8, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,372 | $1.2M | 19.3% | Plan not stated | SEC |
| May 8, 2020 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 22,850 | $5M | 29.7% | Unusual | SEC |
| May 1, 2020 | Wood Larry L | CVP, TAVR | Form 4 sale | 3,566 | $767k | 2.9% | Plan not stated | SEC |
| Apr 27, 2020 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Form 4 sale | 3,470 | $776k | 7.6% | Plan not stated | SEC |
| Apr 16, 2020 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 1,116 | $242k | 7.0% | Plan not stated | SEC |
| Apr 13, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 3,911 | $833k | 11.1% | Plan not stated | SEC |
| Apr 7, 2020 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 22,850 | $4.6M | 32.7% | Unusual | SEC |
| Apr 3, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,369 | $980k | 20.5% | Plan not stated | SEC |
| Apr 1, 2020 | Wood Larry L | CVP, TAVR | Form 4 sale | 3,566 | $645k | 2.9% | Plan not stated | SEC |
| Apr 1, 2020 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Form 4 sale | 3,470 | $628k | 7.6% | Plan not stated | SEC |
| Mar 30, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 4,948 | $980k | 13.7% | Plan not stated | SEC |
| Mar 23, 2020 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 1,116 | $182k | 6.6% | Plan not stated | SEC |
| Mar 19, 2020 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 22,850 | $4.1M | 32.7% | Unusual | SEC |
| Mar 6, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,369 | $1.1M | 20.6% | Plan not stated | SEC |
| Mar 2, 2020 | Wood Larry L | CVP, TAVR | Form 4 sale | 3,566 | $738k | 2.9% | Plan not stated | SEC |
| Feb 27, 2020 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Form 4 sale | 3,470 | $755k | 7.7% | Plan not stated | SEC |
| Feb 18, 2020 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 2,500 | $571k | 12.9% | Plan not stated | SEC |
| Feb 10, 2020 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 22,850 | $5.2M | 32.7% | Unusual | SEC |
| Feb 7, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,369 | $1.3M | 20.6% | Plan not stated | SEC |
| Feb 5, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 4,650 | $1.1M | 12.6% | Plan not stated | SEC |
| Feb 3, 2020 | Wood Larry L | CVP, TAVR | Form 4 sale | 3,566 | $783k | 2.9% | Plan not stated | SEC |
| Feb 3, 2020 | Szyman Catherine M. | CVP, Critical Care | Form 4 sale | 2,500 | $549k | 12.9% | Plan not stated | SEC |
| Feb 3, 2020 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Form 4 sale | 3,470 | $762k | 7.7% | Plan not stated | SEC |
| Jan 10, 2020 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Form 4 sale | 5,369 | $1.3M | 20.6% | Plan not stated | SEC |
| Jan 7, 2020 | Ullem Scott B. | CVP, Chief Financial Officer | Form 4 sale | 7,500 | $1.8M | 43.0% | Unusual | SEC |
| Jan 6, 2020 | Wang Huimin | CVP, Japan & Intercontinental | Form 4 sale | 4,650 | $1.1M | 12.6% | Plan not stated | SEC |
| Jan 3, 2020 | Mussallem Michael A | Chairman & CEO | Form 4 sale | 22,850 | $5.3M | 32.7% | Unusual | SEC |